REPLIMUNE GROUP INC

Ticker: REPL CUSIP: 76029N106 Class: Common Stock

Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023

Shares 386,762 Value ($000) $6,617 Avg Close $19.64 Range $15.62 - $23.60

Q2 2023

Shares 386,762 Value ($000) $8,981 Avg Close $19.54 Range $15.51 - $24.81

Q1 2023

Shares 686,762 Value ($000) $12,128 Avg Close $23.78 Range $16.89 - $29.52

Q4 2022

Shares 931,560 Value ($000) $25,338 Avg Close $20.78 Range $16.68 - $28.17

Q3 2022

Shares 806,267 Value ($000) $13,924 Avg Close $19.07 Range $15.07 - $21.63

Q2 2022

Shares 806,267 Value ($000) $14,094 Avg Close $16.43 Range $13.05 - $20.54

Q1 2022

Shares 716,762 Value ($000) $12,171 Avg Close $18.87 Range $14.97 - $30.89

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2023	386,762	$6,617	$19.64	$15.62 - $23.60
Q2 2023	386,762	$8,981	$19.54	$15.51 - $24.81
Q1 2023	686,762	$12,128	$23.78	$16.89 - $29.52
Q4 2022	931,560	$25,338	$20.78	$16.68 - $28.17
Q3 2022	806,267	$13,924	$19.07	$15.07 - $21.63
Q2 2022	806,267	$14,094	$16.43	$13.05 - $20.54
Q1 2022	716,762	$12,171	$18.87	$14.97 - $30.89